Smoking Cessation Therapy Considerations for Patients With Chronic Kidney Disease

Smoking Cessation Therapy Considerations for Patients With Chronic Kidney Disease

Identification: nnj_ja08A2
Issue: July-August 2008
Volume: Vol. 35, No. 4

Standard: $30.00

Description

This article is available to members for free.

Goal: To increase awareness about smoking cessation therapy for patients with chronic kidney disease.

Objectives:

  1. Explain how nicotine replacement therapy, bupropion, and varenicline are used as methods of smoking cessation therapy.
  2. Describe the pharmacokinetics of bupropion and varenicline.
  3. Discuss smoking cessation outcomes in patients with CKD.


Disclosure Statement: The authors reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content

References